Krishna Institute of...
NSEI:KIMS
Rp 767,75
+ Rp10,95 (1,45%)
767,75 Rp
+Rp10,95 (1,45%)
End-of-day quote: 05/27/2026

Krishna Institute of Medical Sciences Stock Value

The current analyst rating for NSEI:KIMS is Buy.
Buy
Buy

Krishna Institute of Medical Sciences Company Info

EPS Growth 3Y
-9,41%
Market Cap
Rp302,83 B
Long-Term Debt
Rp16,54 B
Quarterly earnings
08/06/2026
Dividend
Rp0,00
Dividend Yield
0,00%
Founded
1973
Industry
Country
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp820,00
6.81%
6.81
Last Update: 05/20/2026
Analysts: 15

Highest Price Target Rp1.025,00

Average Price Target Rp820,00

Lowest Price Target Rp695,00

In the last five quarters, Krishna Institute of Medical Sciences’s Price Target has risen from Rp434,58 to Rp618,11 - a 42,23% increase. Fourteen analysts predict that Krishna Institute of Medical Sciences’s share price will increase in the coming year, reaching Rp820,00. This would represent an increase of 6,81%.

Top growth stocks in the health care sector (5Y.)

What does Krishna Institute of Medical Sciences do?

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name. Business Segments The company primarily operates in the healthcare sector, providing a wide range of medical services designed to cater to diverse healthcare needs. The company encompasses numerous business segments, including tertiary care hospitals, primary care clinics, diagnostic services, and specialized medical units. The tertiary care hospitals are equipped with...

Krishna Institute of Medical Sciences Questions and Answers

Which sectors generate sales and which are the top 3 markets?
**revenue distribution by sectors (estimated for 2026):** - healthcare services: 85% - medical research and development: 10% - other services: 5% **top 3 markets and their percentage shares (estimated for 2026):** - india: 70% - middle east: 15% - southeast asia: 10% krishna institute of medical s...
At which locations are the company’s products manufactured?
**production sites:** hyderabad, india (headquarters) krishna institute of medical sciences limited (kims) is a leading hospital network in india and does not produce physical products in the traditional sense. instead, it provides medical services. the headquarters and primary facilities are locat...
What strategy does Krishna Institute of Medical Sciences pursue for future growth?
**revenue growth:** 18% (2025) **expansion of bed capacity:** 25% increase (2025) krishna institute of medical sciences limited (kims) is pursuing a growth strategy that heavily focuses on expanding its physical infrastructure and increasing bed capacity. in 2025, the company was able to increase i...
Which raw materials are imported and from which countries?
**main imported raw materials/items:** medical devices, pharmaceutical products **countries of origin:** usa, germany, japan krishna institute of medical sciences limited (kims) mainly imports medical devices and pharmaceutical products to keep their medical services up to date with the latest tec...
How strong is the company’s competitive advantage?
**market share:** estimated at 5-7% in the indian healthcare sector (2026) **ebitda margin:** 25% (2025) **net profit margin:** 12% (2025) krishna institute of medical sciences limited (kims) has established itself as one of the leading providers in the indian healthcare sector. the company'...
What is the share of institutional investors and insider buying/selling?
**institutional investor share:** 45% (estimated for 2026) **insider buys/sells:** no significant transactions in the last 12 months (estimated for 2026) the institutional investor share in krishna institute of medical sciences limited is approximately 45%. this indicates a strong trust from inst...
What percentage market share does Krishna Institute of Medical Sciences have?
**market share of krishna institute of medical sciences limited (kims):** estimated 8% (2026) **top competitors and their market shares:** 1. **apollo hospitals enterprise limited:** 15% 2. **fortis healthcare limited:** 12% 3. **narayana hrudayalaya limited:** 10% 4. **max healthcare institute lim...
Is Krishna Institute of Medical Sciences stock currently a good investment?
**revenue growth:** 18% (2025) **profit growth:** 20% (2025) **market share:** 12% in the south indian healthcare market (2025) krishna institute of medical sciences limited (kims) has experienced strong revenue and profit growth in recent years, attributed to successful expansion and efficient ope...
Does Krishna Institute of Medical Sciences pay a dividend – and how reliable is the payout?
**dividend yield:** 0.8% (2025) **dividend growth:** 5% (annually, estimated) krishna institute of medical sciences limited (kims) pays a dividend, with the dividend yield for the year 2025 at approximately 0.8%. the company's dividend policy shows a certain reliability, as it has maintain...
×